Beam nasdaq

Author: glwm

August undefined, 2024

WebMar 16, 2024 · Beam Therapeutics has a 1 year low of $27.77 and a 1 year high of $73.27. Beam Therapeutics ( NASDAQ:BEAM - Get Rating) last issued its quarterly earnings data on Tuesday, February 28th. The company reported ($0.54) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.34) by $0.80. Web1 day ago · Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of …

Beam Therapeutics Inc. (NASDAQ:BEAM) Receives $72.40 …

WebApr 10, 2024 · Beam Therapeutics Price Performance. NASDAQ:BEAM opened at $29.74 on Monday. The firm has a market capitalization of $2.15 billion, a P/E ratio of -7.20 and a beta of 1.63. The business has a 50 ... Web2 days ago · Beam Therapeutics Inc. is a biotechnology company. The Company is focused on developing precision genetic medicines based on its base editing technology to provide life-long cures to patients suffering from diseases. Its base editing technology enables a new class of precision genetic medicines that targets a single base in the … qwertyuiop au

Beam Therapeutics Inc. (NASDAQ:BEAM) Given Consensus …

WebApr 10, 2024 · Beam Therapeutics Price Performance. NASDAQ:BEAM opened at $29.74 on Monday. The firm has a market capitalization of $2.15 billion, a P/E ratio of -7.20 and … WebBEAM THERAPEUTICS INC. 29.74. at close. +0.42 (‎ +1.43%) after hours • as of Apr 6, 07:51 PM EDT. 29.89. +0.15 (‎ +0.50%) 1D. 5D. shitagi clothes

Beam Therapeutics Inc. Inc. (BEAM) Price Performance: A …

BEAM : BEAM THERAPEUTICS INC. - MSN Money

WebNext quarter’s sales forecast for BEAM is $15.61M with a range of $5.00M to $21.30M. The previous quarter’s sales results were $20.04M. BEAM beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 42.02% of the time in the same period. WebApr 12, 2024 · See the latest Beam Global stock price (NASDAQ:BEEM), related news, valuation, dividends and more to help you make your investing decisions. q w e r t y u i o p a s d f g h j k l 帽WebView the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. shita har design

"WebBeam Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BEAM updated stock price target summary. " - Beam nasdaq

Beam nasdaq

Beam Therapeutics Inc (BEAM) Stock Price & News

WebBEEM Complete Beam Global stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Beam Global started at buy with $23 stock price target at B ... WebBEAM Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 266 Institutional Holders 54,243,673 Total Shares Held Back to BEAM Overview Institutional Holdings...

Did you know?

WebSep 8, 2024 · Find the latest SEC Filings data for Beam Therapeutics Inc. Common Stock (BEAM) at Nasdaq.com. WebJan 16, 2024 · Beam Therapeutics is a preclinical startup that's developing gene therapies and expects to begin clinical trials in the second half of 2024. Its base-editing technology could be a much more...

WebBeam Therapeutics Inc. Common Stock (BEAM) After-Hours Quotes Nasdaq Search for After Hours Quote After-Hours: BEAM Edit my quotes Beam Therapeutics Inc. Common Stock (BEAM) 0 Add to... WebCAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines …

WebApr 6, 2024 · BEAM opened at $29.32 on Thursday. Beam Therapeutics Inc. has a 12 month low of $27.77 and a 12 month high of $73.27. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of -7.10 and a beta of 1.64. The business has a fifty day moving average price of $38.08 and a 200 day moving average price of $42.41. WebApr 11, 2024 · Beam Global. SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV ...

WebMar 16, 2024 · Beam Therapeutics has a 1 year low of $27.77 and a 1 year high of $73.27. Beam Therapeutics ( NASDAQ:BEAM - Get Rating) last issued its quarterly earnings …

WebBEAM Complete Beam Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. qwertyuiop clavierWebApr 13, 2024 · Beam Therapeutics (NASDAQ:BEAM) has a market capitalization of $2.15 billion and generates $60.92 million in revenue each year. The company earns $-289,090,000.00 in net income (profit) each … qwertyuiop cvbnmWebFind real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Beam Therapeutics Inc (NASDAQ:BEAM) 29.76. Delayed Data. As of Apr 12 -0.33 ... qwertyuiopcvWebApr 6, 2024 · About Beam Therapeutics Inc. Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which... shit ain\u0027t sweetWebFeb 8, 2024 · Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. qwertyuiopcvbWebApr 12, 2024 · According to analysts' consensus price target of $26.33, Beam Global has a forecasted upside of 113.9% from its current price of $12.31. Amount of Analyst Coverage Beam Global has only been the subject of 2 research reports in the past 90 days. See Top Rated MarketRank™ Stocks Here About Beam Global (NASDAQ:BEEM) Stock qwertyuiop cvWebGet the latest Beam Global (BEEM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … qwertyuiopert